Cancer (10.36, 0.005); disulfiram (9.83, 0.005); lc3 (8.68, 0.005); proteasome inhibitors (8.68, 0.005); prooxidant (8.68, 0.005). This evidence concerns the gene MAP1LC3A and cancer.